Form 4: Edwards Lifesciences CEO Bernard J. Zovighian Reports Changes in Beneficial Ownership

CEO Bernard J. Zovighian reports transactions involving Edwards Lifesciences Corp stock, including vesting of performance-based restricted stock units and acquisitions through the 401(k) plan.

Summary

• On May 3, 2024, Bernard J. Zovighian disposed of 527 shares of Edwards Lifesciences Corp common stock at a price of $85.06 per share.
• On May 4, 2024, 6,265 shares vested from performance rights at a price of $0.00, and 3,718 shares were disposed of at $85.25.
• Also on May 4, 2024, 6,265 shares were acquired through the exercise of performance rights.
• On May 6, 2024, 580.2601 shares were acquired at $85.7421 per share.
• Following these transactions, Zovighian directly owns 46,835.9005 shares and indirectly owns 3,267.6552 shares through a 401(k).
• The vesting of performance-based restricted stock units was determined by the Compensation and Governance Committee on May 1, 2024, with 117.11% of the target number of shares vesting.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The filing primarily reflects routine transactions related to executive compensation and employee stock purchase plans. The vesting of performance-based units suggests the company met or exceeded performance targets, which is mildly positive.

Positives

• The vesting of performance-based restricted stock units indicates that performance targets were met, suggesting positive company performance.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.

Comparison to Industry Standards

• Executive compensation packages often include performance-based equity awards, such as restricted stock units, to align executive incentives with shareholder value creation.
• The vesting of 117.11% of the target number of shares suggests that the company exceeded its performance goals during the performance period.
• Similar to other companies, Edwards Lifesciences offers an Employee Stock Purchase Plan, allowing employees to acquire company stock at potentially favorable terms.

Stakeholder Impact

• The vesting of performance-based equity may positively impact shareholder sentiment, as it indicates alignment of executive interests with company performance.
• Employees participating in the Employee Stock Purchase Plan benefit from the opportunity to acquire company stock.

Key Dates